Common Contracts
10 similar Underwriting Agreement contracts by Genocea Biosciences, Inc., Advanced Micro Devices Inc, Continental Building Products, Inc., others
Genocea Biosciences, Inc. 53,365,000 Shares of Common Stock ($0.001 par value per share) and 53,365,000 Class A Warrants to Purchase up to 26,682,500 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 19th, 2018 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • New York
Genocea Biosciences, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), (i) 53,365,000 shares (the “Firm Shares”) of common stock, $0.001 par value (the “Common Stock”), of the Company and (ii) 53,365,000 Class A Warrants of the Company to purchase an aggregate of 26,682,500 shares of the Common Stock (the “Firm Warrants”) of the Company. The Company also proposes to grant to the Underwriters an option to purchase up to (i) 8,004,750 additional shares of the Common Stock (the “Option Shares” and together with the Firm Shares, the “Shares”) and/or (ii) 8,004,750 additional Class A Warrants to purchase up to an additional 4,002,375 shares of the Common Stock (the “Option Warrants” and together with the Firm Warrants, the “Warrants”) (such Shares and Warrants (including the Option Shares and the
Genocea Biosciences, Inc. 1,635 Shares of Series A Convertible Preferred Stock ($0.001 par value per share) and 1,635,000 Class A Warrants to Purchase up to 817,500 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 19th, 2018 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • New York
Genocea Biosciences, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), (i) 1,635 shares (the “Shares”) of the Company’s Series A preferred stock, $0.001 par value (the “Preferred Stock”), which are convertible into 1,635,000 shares of common stock, $0.001 par value (the “Common Stock”), of the Company, and (ii) 1,635,000 Class A Warrants of the Company to purchase 817,500 shares of Common Stock (the “Warrants”, such Shares and Warrants to be issued and sold by the Company being hereinafter collectively called the “Securities”). Each Share is being sold together with 1,000 Warrants, each of which Warrant to purchase 0.5 shares of Common Stock at an exercise price of $1.20 per whole share. As used herein, “Conversion Shares” means Common Stock issuable upon conversion of the Shares, and “Warran
CONTINENTAL BUILDING PRODUCTS, INC. 7,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • November 17th, 2014 • Continental Building Products, Inc. • Concrete, gypsum & plaster products • New York
This is to confirm the agreement among the Selling Stockholder, the Company and the Underwriters concerning the purchase of the Securities from the Selling Stockholder by the Underwriters.
Sophiris Bio Inc. [ ] Common Shares (no par value) Underwriting AgreementUnderwriting Agreement • August 7th, 2013 • Sophiris Bio Inc. • Pharmaceutical preparations • New York
Sophiris Bio Inc., a corporation organized under the laws of British Columbia, Canada (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ — ] of the Company’s common shares, no par value (“Common Shares”) (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ — ] additional Common Shares to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Ce
YuMe, Inc. [ ] Shares(1) Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • July 25th, 2013 • YuMe Inc • Services-advertising agencies • New York
Citigroup Global Markets Inc. Deutsche Bank Securities Inc. Barclays Capital Inc. As Representatives of the several Underwriters,
Underwriting AgreementUnderwriting Agreement • October 23rd, 2012 • Singulex Inc • Services-medical laboratories • New York
Singulex, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ ] shares of common stock, $0.001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ ] additional shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Certai
Spirit Airlines, Inc. Shares Common Stock ($0.0001 par value) Form of Underwriting AgreementUnderwriting Agreement • May 12th, 2011 • Spirit Airlines, Inc. • Air transportation, scheduled • New York
Spirit Airlines, Inc., a corporation incorporated under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, shares of common stock, $0.0001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The persons named in Schedule II hereto (the “Selling Stockholders”) propose to grant to the Underwriters an option to purchase up to shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singula
Underwriting AgreementUnderwriting Agreement • October 1st, 2007 • Daystar Technologies Inc • Semiconductors & related devices • New York
DayStar Technologies, Inc., proposes to sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as representatives (the “Representative”), 15,000,000 shares of common stock, par value $0.01 per share (“Common Stock”), of DayStar Technologies, Inc., a Delaware corporation (the “Company”) (said shares hereinafter called the “Underwritten Securities”). In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,250,000 shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the term Underwriters shall mean either the singular or plural as the context requires. Certain terms used herein are
Spansion Inc. 35,000,000 Sharesa/ Class A Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • November 21st, 2006 • Advanced Micro Devices Inc • Semiconductors & related devices • New York
AMD Investments, Inc., a corporation incorporated under the laws of Delaware (“AMDI”), and Fujitsu Limited, a corporation incorporated under the laws of Japan (“Fujitsu”, and together with AMDI, the “Selling Stockholders” and each a “Selling Stockholder”), propose to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 35,000,000 shares of Class A Common Stock, par value $0.001 per share (“Common Stock”) of Spansion Inc., a corporation incorporated under the laws of Delaware (the “Company”), (said shares hereinafter called (the “Underwritten Securities”). The number of Underwritten Securities sold by each Selling Stockholder shall be as set forth on Schedule II hereto. The Company proposes to grant to the Underwriters an option to purchase up to 5,250,000 newly issued shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the U
MedicalCV, Inc. [ ] Shares* Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • June 6th, 2006 • Medicalcv Inc • Surgical & medical instruments & apparatus • New York
MedicalCV, Inc., a Minnesota corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ ] shares of Common Stock, $0.01 par value (“Common Stock”) of the Company, (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ ] additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires.
